Business Context and Reporting Period
Company: Harvard Bioscience, Inc.
Filing Type: Form 8-K (Current Report)
Report Date: July 29, 2004
Reporting Period: Quarter ended June 30, 2004
Context: This filing serves to announce the company's financial results for the quarter ended June 30, 2004, via a press release incorporated by reference as Exhibit 99.1.
Key Financial Metrics
The provided filing text does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the referenced press release (Exhibit 99.1), which is not included in the input text.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. It only confirms the issuance of results for the quarter ended June 30, 2004.
Guidance, Outlook, and Risks
The filing text does not include management commentary, forward-looking guidance, risk factors, contingencies, or unusual items. Such information is expected to be found in the attached press release (Exhibit 99.1).
Investor Verification Checklist
- Review the full text of the press release (Exhibit 99.1) for specific revenue and earnings figures for the quarter ended June 30, 2004.
- Verify year-over-year and quarter-over-quarter performance metrics not present in this summary.
- Check for any forward-looking statements or guidance provided in the press release.
- Confirm the company's liquidity position and debt levels as detailed in the referenced exhibit.